Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Current Assets: 2023-2025

Historic Current Assets for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $695.8 million.

  • CG Oncology's Current Assets rose 26.03% to $695.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $695.8 million, marking a year-over-year increase of 26.03%. This contributed to the annual value of $754.2 million for FY2024, which is 288.52% up from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Current Assets is $695.8 million, which was up 3.38% from $673.0 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Current Assets ranged from a high of $754.2 million in Q4 2024 and a low of $194.1 million during Q4 2023.
  • Over the past 3 years, CG Oncology's median Current Assets value was $625.8 million (recorded in 2024), while the average stood at $589.1 million.
  • Data for CG Oncology's Current Assets shows a peak YoY skyrocketed of 288.52% (in 2024) over the last 5 years.
  • Over the past 3 years, CG Oncology's Current Assets (Quarterly) stood at $194.1 million in 2023, then surged by 288.52% to $754.2 million in 2024, then rose by 26.03% to $695.8 million in 2025.
  • Its last three reported values are $695.8 million in Q3 2025, $673.0 million for Q2 2025, and $701.2 million during Q1 2025.